GC
AGN

Guggenheim Capital’s Allergan plc AGN Stock Holding History

Guggenheim Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-35,008
Closed -$6.2M – 1979
2020
Q1 		$6.2M Sell
35,008
-4,945
-12% -$931K 0.06% 365
2019
Q4 		$7.64M Buy
39,953
+158
+0.4% +$28.5K 0.06% 421
2019
Q3 		$6.7M Sell
39,795
-28,683
-42% -$4.67M 0.05% 457
2019
Q2 		$11.5M Buy
68,478
+1,063
+2% +$147K 0.09% 248
2019
Q1 		$9.87M Sell
67,415
-14,597
-18% -$2.12M 0.08% 293
2018
Q4 		$11M Sell
82,012
-10,562
-11% -$1.73M 0.09% 231
2018
Q3 		$17.6M Buy
92,574
+22,786
+33% +$4.19M 0.11% 173
2018
Q2 		$11.6M Sell
69,788
-254,863
-79% -$40.9M 0.08% 288
2018
Q1 		$54.6M Buy
324,651
+13,651
+4% +$2.29M 0.13% 247
2017
Q4 		$50.9M Buy
311,000
+61,245
+25% +$11M 0.12% 324
2017
Q3 		$51.2M Sell
249,755
-17,928
-7% -$4.17M 0.12% 287
2017
Q2 		$65.1M Sell
267,683
-10,778
-4% -$2.53M 0.17% 142
2017
Q1 		$66.5M Sell
278,461
-23,440
-8% -$5.46M 0.18% 116
2016
Q4 		$63.4M Buy
301,901
+100,409
+50% +$20.8M 0.18% 112
2016
Q3 		$46.4M Buy
201,492
+5,031
+3% +$1.23M 0.14% 203
2016
Q2 		$45.4M Buy
196,461
+16,703
+9% +$3.85M 0.14% 210
2016
Q1 		$48.2M Sell
179,758
-19,818
-10% -$5.67M 0.15% 171
2015
Q4 		$62.4M Sell
199,576
-106,871
-35% -$31.8M 0.18% 105
2015
Q3 		$83.3M Sell
306,447
-38,751
-11% -$11.9M 0.26% 38
2015
Q2 		$105M Buy
345,198
+38,733
+13% +$11.6M 0.26% 24
2015
Q1 		$91.2M Buy
306,465
+39,154
+15% +$11.2M 0.22% 57
2014
Q4 		$68.8M Sell
267,311
-23,601
-8% -$5.9M 0.17% 109
2014
Q3 		$70.2M Buy
290,912
+17,740
+6% +$3.97M 0.17% 98
2014
Q2 		$60.9M Buy
273,172
+14,575
+6% +$3.02M 0.15% 128
2014
Q1 		$53.2M Buy
258,597
+26,667
+11% +$5.28M 0.15% 133
2013
Q4 		$39M Buy
231,930
+11,253
+5% +$1.76M 0.12% 206
2013
Q3 		$31.8M Buy
220,677
+28,875
+15% +$3.85M 0.11% 206
2013
Q2 		$24.2M Buy
+191,802
New +$21.7M 0.1% 251

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Guggenheim Capital's AGN Position: Q2 2020 in Review

Guggenheim Capital sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 35,008 shares — an estimated $6.2M sold.

Guggenheim Capital first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $105M in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Guggenheim Capital reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Guggenheim Capital sold 35,008 Allergan plc shares in Q2 2020, an estimated $6.2M.
  • Guggenheim Capital first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Guggenheim Capital's Allergan plc position peaked at $105M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Guggenheim Capital's 13F filing for Q2 2020, filed 14 Aug 2020.